DE69303569T2 - Arylalkyl(thio)amide mit Melatonin-Rezeptor-Selektivität und Prozess zu ihrer Darstellung - Google Patents
Arylalkyl(thio)amide mit Melatonin-Rezeptor-Selektivität und Prozess zu ihrer DarstellungInfo
- Publication number
- DE69303569T2 DE69303569T2 DE69303569T DE69303569T DE69303569T2 DE 69303569 T2 DE69303569 T2 DE 69303569T2 DE 69303569 T DE69303569 T DE 69303569T DE 69303569 T DE69303569 T DE 69303569T DE 69303569 T2 DE69303569 T2 DE 69303569T2
- Authority
- DE
- Germany
- Prior art keywords
- arylalkyl
- thio
- amides
- preparation
- lower alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/20—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/60—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9211671A FR2696453B1 (fr) | 1992-10-02 | 1992-10-02 | Nouveaux arylalkyl(thio)amides, leur procédé de préparation, et les compositions pharmaceutiques qui les contiennent. |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69303569D1 DE69303569D1 (de) | 1996-08-14 |
DE69303569T2 true DE69303569T2 (de) | 1997-02-20 |
Family
ID=9434060
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69303569T Expired - Fee Related DE69303569T2 (de) | 1992-10-02 | 1993-10-01 | Arylalkyl(thio)amide mit Melatonin-Rezeptor-Selektivität und Prozess zu ihrer Darstellung |
Country Status (13)
Country | Link |
---|---|
US (4) | US5464872A (de) |
EP (1) | EP0591057B1 (de) |
JP (1) | JP2564462B2 (de) |
AT (1) | ATE140214T1 (de) |
AU (1) | AU660854B2 (de) |
CA (1) | CA2107484C (de) |
DE (1) | DE69303569T2 (de) |
DK (1) | DK0591057T3 (de) |
ES (1) | ES2091575T3 (de) |
FR (1) | FR2696453B1 (de) |
GR (1) | GR3021193T3 (de) |
NZ (1) | NZ248842A (de) |
ZA (1) | ZA937309B (de) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0753147A1 (de) * | 1994-03-30 | 1997-01-15 | Novartis AG | Screeningsverfahren unter verwendung der rzr rezeptorfamilie |
US5403851A (en) * | 1994-04-05 | 1995-04-04 | Interneuron Pharmaceuticals, Inc. | Substituted tryptamines, phenalkylamines and related compounds |
US7081349B1 (en) | 1994-06-17 | 2006-07-25 | The General Hospital Corporation | High-affinity melatonin receptor and uses thereof |
US5856124A (en) | 1994-06-17 | 1999-01-05 | The General Hospital Corporation | DNA encoding high-affinity melatonin receptors |
US5849769A (en) | 1994-08-24 | 1998-12-15 | Medivir Ab | N-arylalkyl-N-heteroarylurea and guandine compounds and methods of treating HIV infection |
US5496826A (en) * | 1994-09-02 | 1996-03-05 | Bristol-Myers Squibb Company | Pharmaceutical methods of using heterocyclic derivatives of N-phenylamides |
EP0781271B1 (de) * | 1994-09-12 | 2000-06-07 | Takeda Chemical Industries, Ltd. | Benzozykloalkenverbindungen, deren herstellung und verwendung |
US5541228A (en) * | 1994-10-14 | 1996-07-30 | Bristol-Myers Squibb Co. | Melatonergic agents |
FR2726268B1 (fr) * | 1994-10-26 | 1996-12-06 | Adir | Nouvelles o-arylmethyl n-(thio)acyl hydroxylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent |
US5530012A (en) * | 1994-12-22 | 1996-06-25 | Bristol-Myers Squibb Co. | 3-alkoxybenzylpiperidine derivatives as melatonergic agents |
US5661186A (en) * | 1995-02-24 | 1997-08-26 | Bristol-Myers Squibb Co. | Tetralinyl-and indanyl-ethylamides |
FR2734816B1 (fr) * | 1995-05-31 | 1997-07-04 | Adir | Nouveaux aryl (alkyl) propylamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2734814B1 (fr) * | 1995-05-31 | 1997-07-04 | Adir | Nouveaux composes alkoxy-aryles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US5596019A (en) * | 1995-06-07 | 1997-01-21 | Bristol-Myers Squibb Company | N-acyl-cycloalkylamine derivatives as melatonergics |
US5753709A (en) * | 1995-06-07 | 1998-05-19 | Bristol-Myers Squibb Company | N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics |
ATE275132T1 (de) * | 1995-06-27 | 2004-09-15 | Takeda Chemical Industries Ltd | 4-acylamino(halogen)alkyl-chinolin derivate, deren herstellung und deren verwendung als melatonin-agonisten |
FR2741799B1 (fr) * | 1995-12-04 | 1998-01-02 | Oreal | Utilisation de melatonine dans une composition pour traiter les signes cutanes des etats de fatigue |
US6992188B1 (en) | 1995-12-08 | 2006-01-31 | Pfizer, Inc. | Substituted heterocyclic derivatives |
FR2746313B1 (fr) * | 1996-03-22 | 1998-04-17 | Adir | Utilisation de la melatonine et des ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention et au traitement du diabete et des complications diabetiques |
US5808151A (en) * | 1996-04-17 | 1998-09-15 | Bristol-Myers Squibb Company | Biphenylamido derivatives as melatonergic agents |
BR9713690B1 (pt) * | 1996-12-10 | 2009-08-11 | agentes melatoninérgicos benzodioxola, benzofurano, diidrobenzofurano e benzodioxano. | |
US5958964A (en) * | 1997-02-18 | 1999-09-28 | South Alabama Medical Science Foundation | Use of melatonin to prevent cytotoxic effects of amyloid beta protein |
FR2763335B1 (fr) * | 1997-05-16 | 2000-11-24 | Adir | Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6028112A (en) * | 1997-05-23 | 2000-02-22 | Bristol-Myers Squibb Company | Spirocyclopropyl fluorenes as melatonergic agents |
FR2771739B1 (fr) * | 1997-11-28 | 2001-04-20 | Adir | Nouveaux composes naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6090854A (en) * | 1998-03-20 | 2000-07-18 | Bristol-Meyers Company | Aryloxyanilides and related compounds |
WO1999062515A1 (en) | 1998-06-05 | 1999-12-09 | Bristol-Myers Squibb Company | Heterocyclic cis cyclopropane derivatives as melatonergic agents |
PE20000942A1 (es) * | 1998-07-31 | 2000-09-28 | Lilly Co Eli | Derivados de amida, carbamato y urea |
US6617351B1 (en) | 1998-07-31 | 2003-09-09 | Eli Lilly And Company | Amide, carbamate, and urea derivatives |
FR2793793B1 (fr) * | 1999-05-19 | 2004-02-27 | Adir | Nouveaux derives dimeriques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
WO2001007654A1 (en) * | 1999-07-22 | 2001-02-01 | The General Hospital Corporation | Method for identifying compounds which modulate circadian rhythm |
US7632972B2 (en) * | 2003-10-30 | 2009-12-15 | The Board Of Trustees Of The University Of Illionis | Compounds and methods for treatment of cancer and modulation of programmed cell death for melanoma and other cancer cells |
FR2919606B1 (fr) * | 2007-08-03 | 2010-09-17 | Servier Lab | Nouveau procede de synthese du (7-methoxy-1-naphtyl) acetonitrile et application a la synthese de l'agomelatine. |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1959898U (de) | 1966-01-03 | 1967-05-03 | Christoph Gubbels | Geraet zum magnetischen aufsammeln von verstreuten kleineisenteilen. |
NL6917600A (de) * | 1968-11-29 | 1970-06-02 | ||
US3944675A (en) * | 1973-03-15 | 1976-03-16 | Schering Corporation | Substituted aryl and aralkyl amides in the treatment of parkinsonism |
DE3030047A1 (de) * | 1980-08-08 | 1982-03-11 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue aminopropanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
JPS6056944A (ja) * | 1983-04-22 | 1985-04-02 | Rikagaku Kenkyusho | クロルアセトアミド誘導体、その製造方法およびそれを有効成分とする除草剤 |
US5059620A (en) * | 1985-12-27 | 1991-10-22 | The Du Pont Merck Pharmaceutical Company | Aryl substituted aminomethyl benzene derivatives |
US4925877A (en) * | 1986-02-25 | 1990-05-15 | Zaidanhojin Biseibutsu Kagaku Kenkyukai | Physiologically active erbstatin analogue compounds and compositions |
US5283343A (en) * | 1987-08-17 | 1994-02-01 | Whitby Research, Inc. | 2-aryl substituted N-acetyltryptamines and process of preparing such |
FR2658818B1 (fr) * | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
-
1992
- 1992-10-02 FR FR9211671A patent/FR2696453B1/fr not_active Expired - Fee Related
-
1993
- 1993-10-01 NZ NZ248842A patent/NZ248842A/en unknown
- 1993-10-01 DE DE69303569T patent/DE69303569T2/de not_active Expired - Fee Related
- 1993-10-01 AU AU48729/93A patent/AU660854B2/en not_active Ceased
- 1993-10-01 ES ES93402394T patent/ES2091575T3/es not_active Expired - Lifetime
- 1993-10-01 ZA ZA937309A patent/ZA937309B/xx unknown
- 1993-10-01 EP EP93402394A patent/EP0591057B1/de not_active Expired - Lifetime
- 1993-10-01 DK DK93402394.6T patent/DK0591057T3/da active
- 1993-10-01 JP JP5278806A patent/JP2564462B2/ja not_active Expired - Lifetime
- 1993-10-01 AT AT93402394T patent/ATE140214T1/de not_active IP Right Cessation
- 1993-10-01 CA CA002107484A patent/CA2107484C/fr not_active Expired - Fee Related
-
1995
- 1995-01-18 US US08/375,503 patent/US5464872A/en not_active Expired - Fee Related
- 1995-05-22 US US08/446,323 patent/US5604261A/en not_active Expired - Fee Related
- 1995-05-22 US US08/446,409 patent/US5554642A/en not_active Expired - Fee Related
-
1996
- 1996-03-11 US US08/613,707 patent/US5708020A/en not_active Expired - Fee Related
- 1996-09-30 GR GR960402548T patent/GR3021193T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0591057B1 (de) | 1996-07-10 |
US5464872A (en) | 1995-11-07 |
CA2107484C (fr) | 2000-09-19 |
CA2107484A1 (fr) | 1994-04-03 |
GR3021193T3 (en) | 1996-12-31 |
US5554642A (en) | 1996-09-10 |
EP0591057A1 (de) | 1994-04-06 |
JP2564462B2 (ja) | 1996-12-18 |
JPH07316113A (ja) | 1995-12-05 |
DE69303569D1 (de) | 1996-08-14 |
ES2091575T3 (es) | 1996-11-01 |
US5604261A (en) | 1997-02-18 |
ZA937309B (en) | 1994-04-22 |
NZ248842A (en) | 1995-07-26 |
AU660854B2 (en) | 1995-07-06 |
FR2696453A1 (fr) | 1994-04-08 |
DK0591057T3 (da) | 1996-11-11 |
US5708020A (en) | 1998-01-13 |
AU4872993A (en) | 1994-04-14 |
FR2696453B1 (fr) | 1994-12-23 |
ATE140214T1 (de) | 1996-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69303569D1 (de) | Arylalkyl(thio)amide mit Melatonin-Rezeptor-Selektivität und Prozess zu ihrer Darstellung | |
FI931888A0 (fi) | Kramploesande cykliska fruktopyranossulfiter -och sulfater | |
HU9302372D0 (en) | Non-aromatic heterocyclic compounds containing nitrogen being substituted with substituted benzyl-amino group | |
PH31123A (en) | Benzimidazole compounds. | |
DE3785315D1 (de) | Erythromycin-a-derivate und verfahren zu ihrer herstellung. | |
ATE91684T1 (de) | 1,2-cyclohexylaminoarylamide zu verwendung als analgetika. | |
NO975663L (no) | Semikarbazoner med CNS aktivitet og farmasöytiske preparater inneholdende de samme | |
ATE58126T1 (de) | Aminderivate, verfahren zu ihrer herstellung und diese enthaltende fungizide. | |
ATE134623T1 (de) | Salicyl(thio)etherderivate, verfahren und zwischenprodukte zu ihrer herstellung | |
ATE93230T1 (de) | Diharnstoffderivate, verwendbar als medikamente, und verfahren zu deren herstellung. | |
EP0714900A3 (de) | Alkylhydrogenchlorsilane, Verfahren zu deren Herstellung und deren Verwendung | |
DE69019920D1 (de) | Benzocycloalkylaminopyridinamine und verwandte Verbindungen, Verfahren zu ihrer Herstellung, Zwischenverbindungen und ihre Verwendung als Arzneimittel. | |
GR3029450T3 (en) | Triazospirodecanone-methyl-chromans for the treatment of central nervous system illnesses | |
DE59300094D1 (de) | Verfahren zur Herstellung von 2-Chlor-5-chlormethyl-pyridin. | |
DE69227207D1 (de) | 1-Piperazinyl-2-butene und 2-butyne, Zwischenverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
ATE33644T1 (de) | Harnstoffderivate. | |
ATE163177T1 (de) | N-acyloxyalkyl-carbonsäureamide und verfahren zu ihrer herstellung | |
ATE123279T1 (de) | Substituierte 9-amino-spiro(cycloalkyl(b>chinolin-2,1'cycloal ane>, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel. | |
ATE179417T1 (de) | Glyceraldehyd-3-pentanid und verfahren zu ihrer herstellung | |
ES2107562T3 (es) | Amidas de acidos alfa-aril-alfa-hidroxi-beta-imidazolinil-propanoicos. | |
DK0662474T3 (da) | Fremgangsmåde til fremstilling af chlorpyridiner | |
ATE157961T1 (de) | Acetaldehyd-derivate, verfahren zu ihrer herstellung und ihre verwendung | |
TH20331A (th) | การใช้อนุพันธุ์ 5-ซับสทิทิวเทค ไพริดีน-และเฮกซะไฮโดร-ควิโนลีน-3-คาร์บอกซลิค แอซิค |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: LES LABORATOIRES SERVIER, NEUILLY SUR SEINE, FR |
|
8339 | Ceased/non-payment of the annual fee |